Is Hip Range of Motion Relevant in the Treatment of Chronic Low Back Pain?

September 6, 2022 updated by: Alexander Achalandabaso, University of Jaen

Impact of Manual Therapy on the Coxofemoral Joint in Patients With Chronic Low Back Pain of Non-Specific Origin.

The study will be carried out at the Faculty of Nursing and Physiotherapy of the University of Alcalá. The study has been approved by the Animal Research and Experimentation Ethics Committee of the University of Alcalá. A total of 60 subjects aged between 18 and 35 with non.specific low back pain will be selected and randomized in two interventions.

The control group will carry out a specific strengthening program for the gluteus maximus and the experimental group will carry out the same strengthening program in addition to receiving a specific manual therapy program for both hips.

The total duration of the treatments will be 8 weeks, with on-treatment evaluations at 4 and 8 weeks, with a follow-up after 1 month.

The objective will be to determine the efficacy of manual therapy on the coxofemoral joint together with a protocol of gluteus maximus strengthening exercises in patients with non-specific chronic low back pain, in comparison with the same protocol of gluteus maximus strengthening exercises performed in isolation, in patients with non-specific chronic low back pain.

Study Overview

Status

Completed

Detailed Description

Detailed Description has not been entered.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alcalá De Henares
      • Madrid, Alcalá De Henares, Spain, 28801
        • Manuel Rojas

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with non-specific low back pain, with a score of more than 2 on the visual analogue scale.
  • Pain with a course of more than 12 weeks, of a chronic nature.

Exclusion Criteria:

  • Patients with neurological signs and symptoms or severe psychiatric illnesses.
  • Subjects with a history of severe trauma, fracture or previous surgery on the lumbar spine or hip.
  • Subjects with a history of musculoskeletal and/or rheumatologic disease.
  • Patients with low back pain attributable to dysmenorrhoea.
  • Pregnant patients.
  • Individuals with fibromyalgia, autoimmune disorders.
  • Subjects with a history of oncological processes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Control Group. Gluteus maximus strengthening specific program

All subjects will carry out a gluteus maximus strengthening work out. The exercises should be performed at a frequency of 3 times/week and with a dosage of 3 sets of 8 repetitions.

1-4 Weeks: 1. Bilateral gluteal bridge: Supine decubitus with knees and hips bent and feet supported. To raise the pelvis until the knees are flexed to 90° and then returns to the starting position. 2.Clam shell: Lateral decubitus with knees and hips bent to 45º, working leg placed on top of the other. Separate this knee while feet remain in contact using a medium density Theraband on the distal thighs. Bilateral work. 3. Side-Step: Bipedestation with Knees and hips bent. The exercise then consists of two steps taken in one direction followed by two steps in the opposite direction to return to the starting position. The elastic band shall be placed above the knees.

4-8 Weeks: 1.Unilateral gluteal bridge. 2 Clam shell: hips bents to 60º. 3. Side-Step: placing the elastic band over the ankles

Experimental: Intervention group. Specific manual therapy program for hip joint and Gluteus maximus strengthening

All subjects will carry out a gluteus maximus strengthening work out. The exercises should be performed at a frequency of 3 times/week and with a dosage of 3 sets of 8 repetitions.

1-4 Weeks: 1. Bilateral gluteal bridge: Supine decubitus with knees and hips bent and feet supported. To raise the pelvis until the knees are flexed to 90° and then returns to the starting position. 2.Clam shell: Lateral decubitus with knees and hips bent to 45º, working leg placed on top of the other. Separate this knee while feet remain in contact using a medium density Theraband on the distal thighs. Bilateral work. 3. Side-Step: Bipedestation with Knees and hips bent. The exercise then consists of two steps taken in one direction followed by two steps in the opposite direction to return to the starting position. The elastic band shall be placed above the knees.

4-8 Weeks: 1.Unilateral gluteal bridge. 2 Clam shell: hips bents to 60º. 3. Side-Step: placing the elastic band over the ankles

All subjects will receive a specific program of manual therapy on the hip joint. 10 sessions of manual therapy will be applied during 8 weeks, 1 session per week, except the first week when two sessions will be applied.

The protocol consists of passive manual joint therapy at low speed on the hip, applying each mobilization in 3 series of 10 repetitions. It also includes muscle stretching, performing 3 series and holding the stretch for 25 seconds.

Manual therapy includes: 1. Anteroposterior (AP) and posteroanterior (PA) displacement of the hip. 2. Lateromedial and mediolateral displacement of the hip. 3. Distraction of the long axis/traction of the hip. 4. Lower slip in internal rotation (IR) and external rotation (ER) of the hip. 5. Iliopsoas stretch. 6. Piriformis stretch.To perform the protocol, the patient shall be placed in the supine decubitus position.

In addition to the same gluteus maximus strengthening programme used for the control group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Pain
Time Frame: Baseline, 4 weeks, 8weeks, 1 month after intervention commencement

measured with visual analogic scale

A straight horizontal line of fixed length, usually 100 mm is drawn. The ends are defined as the extreme limits of the parameter to be measured (pain) orientated from the left (worst) to the right (best).

Baseline, 4 weeks, 8weeks, 1 month after intervention commencement

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in Disability
Time Frame: Baseline, 4 weeks, 8weeks, 1 month after intervention commencement

measured with the Oswestry Low Back Pain Disability Questionnaire. The interpretation of the scores of this scale varies from 0% to 100%.

  • 0% to 20%: minimal disability: The patient can cope with most living activities.
  • 21%-40%: moderate disability.
  • 41%-60%: severe disability.
  • 61%-80%: crippled.
  • 81%-100%: These patients are either bed-bound or exaggerating their symptoms.
Baseline, 4 weeks, 8weeks, 1 month after intervention commencement
Changes in Health related quality of life
Time Frame: Baseline, 4 weeks, 8weeks, 1 month after intervention commencement
Using SF-36. This scale is made up of 36 items divided into 8 sections: Physical Function, Function Social, Physical role, Emotional role, Mental health, Vitality, Body pain, General Health. For each of the 8 dimensions, the items are coded, aggregated and transformed into a scale that ranges from 0 (the worst state of health for that dimension) to 100 (the best state of health).
Baseline, 4 weeks, 8weeks, 1 month after intervention commencement
Changes in Depression
Time Frame: Baseline, 4 weeks, 8weeks, 1 month after intervention commencement

measured with Beck's Depression Inventory

When the test is scored, a value of 0 to 3 is assigned for each answer and then the total score is compared to a key to determine the depression's severity. The standard cut-off scores were as follows:

  • 0-9: indicates minimal depression
  • 10-18: indicates mild depression
  • 19-29: indicates moderate depression
  • 30-63: indicates severe depression.

Higher total scores indicate more severe depressive symptoms.

Baseline, 4 weeks, 8weeks, 1 month after intervention commencement
Changes in Gluteus Maximus Strength
Time Frame: Baseline, 4 weeks, 8weeks, 1 month after intervention commencement

measured with a wireless digital hand-held dynamometer (microFET ® 2). It has a measurement range of 0-300 lbs (pounds). You can select the unit of measurement: pounds, Newtons or Kilogram-force.

The three main actions of the gluteus maximus will be assessed with respect to its action on the hip: abduction, extension and external rotation.

Baseline, 4 weeks, 8weeks, 1 month after intervention commencement
Changes in the Range of Motion of the Hip Joint
Time Frame: Baseline, 4 weeks, 8weeks, 1 month after intervention commencement
measured with an 18 cm universal goniometer. The movements to be evaluated are associated with flexion, extension, internal rotation, external rotation, abduction and adduction to end range without pain, explored passively.
Baseline, 4 weeks, 8weeks, 1 month after intervention commencement

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Manuel Rojas, University of Alcalá, Madrid, Spain

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 4, 2022

Primary Completion (Actual)

June 8, 2022

Study Completion (Actual)

July 8, 2022

Study Registration Dates

First Submitted

March 30, 2022

First Submitted That Met QC Criteria

April 11, 2022

First Posted (Actual)

April 14, 2022

Study Record Updates

Last Update Posted (Actual)

September 8, 2022

Last Update Submitted That Met QC Criteria

September 6, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • CEIM/2022/1/002

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Low-back Pain

Clinical Trials on Control group

3
Subscribe